Influenza Drug Therapy

The influenza virus is a common viral infection that can rapidly evolve and render previous vaccines ineffective. There are two types of FDA approved drug treatments for the influenza virus, neuraminidase inhibitors and M2-inhibitors. Discover the latest research on influenza drug therapy here.

January 8, 2021

Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond

Chemical Reviews
Ashley N MatthewCelia A Schiffer
January 20, 2021

In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses.

Computers in Biology and Medicine
Anjali LathwalGajendra P S Raghava
January 15, 2021
Review
Open Access

Designer nucleases to treat malignant cancers driven by viral oncogenes

Virology Journal
Tristan A Scott, Kevin V Morris
January 9, 2021
Open Access

Identification of a universal antigen epitope of influenza A virus using peptide microarray

BMC Veterinary Research
Qiuxia WangXiufan Liu
December 31, 2020
Open Access

Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary.

Animals : an Open Access Journal From MDPI
Anna CostagliolaAntonio Giordano
January 13, 2021

Quadrivalent Influenza Vaccine (Sinovac Biotech) for seasonal influenza prophylaxis

Expert Review of Vaccines
Yan-Yang TaoFeng-Cai Zhu
January 24, 2021
Review

A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.

Archives of Virology
Jyoti Verma, Naidu Subbarao
December 15, 2020
Open Access

Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination

ImmunoHorizons
Priyanka B SubrahmanyamHolden T Maecker
January 6, 2021
Preprint
Open Access

Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions

BioRxiv : the Preprint Server for Biology
Andrea R ShiakolasIvelin S Georgiev
January 14, 2021

Brequinar inhibits enterovirus replication by targeting biosynthesis pathway of pyrimidines

American Journal of Translational Research
Han FuEnqing Fu
January 8, 2021

Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin

Journal of Medical Virology
Yan LitingHu Jun
January 3, 2021
Preprint
Open Access

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

BioRxiv : the Preprint Server for Biology
S. J. ZostJames E Crowe
January 4, 2021
Preprint
Open Access

Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus

BioRxiv : the Preprint Server for Biology
G. A. ArunkumarFlorian Krammer
December 18, 2020
Review

Therapy in Advanced Hepatocellular Carcinoma

Seminars in Interventional Radiology
Hanna JavanNadine Abi-Jaoudeh
January 22, 2021

Self-assembled peptide nanorod vaccine confers protection against influenza A virus.

Biomaterials
Ximena ZottigSteve Bourgault

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved
/feed-previews/influenza-drug-therapy/c666b72e-0a4d-4638-a97a-37979d796eef